Literature DB >> 18644790

Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum.

Daniel Marcellino1, Sergi Ferré, Vicent Casadó, Antonio Cortés, Bernard Le Foll, Carmen Mazzola, Filippo Drago, Oliver Saur, Holger Stark, Aroa Soriano, Chanel Barnes, Steven R Goldberg, Carme Lluis, Kjell Fuxe, Rafael Franco.   

Abstract

The function of dopamine D(3) receptors present in the striatum has remained elusive. In the present study evidence is provided for the existence of dopamine D(1)-D(3) receptor heteromers and for an intramembrane D(1)-D(3) receptor cross-talk in living cells and in the striatum. The formation of D(1)-D(3) receptor heteromers was demonstrated by fluorescence resonance energy transfer and bioluminescence resonance energy transfer techniques in transfected mammalian cells. In membrane preparations from these cells, a synergistic D(1)-D(3) intramembrane receptor-receptor interaction was observed, by which D(3) receptor stimulation enhances D(1) receptor agonist affinity, indicating that the D(1)-D(3) intramembrane receptor-receptor interaction is a biochemical characteristic of the D(1)-D(3) receptor heteromer. The same biochemical characteristic was also observed in membrane preparations from brain striatum, demonstrating the striatal co-localization and heteromerization of D(1) and D(3) receptors. According to the synergistic D(1)-D(3) intramembrane receptor-receptor interaction, experiments in reserpinized mice showed that D(3) receptor stimulation potentiates D(1) receptor-mediated behavioral effects by a different mechanism than D(2) receptor stimulation. The present study shows that a main functional significance of the D(3) receptor is to obtain a stronger dopaminergic response in the striatal neurons that co-express the two receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644790      PMCID: PMC2533781          DOI: 10.1074/jbc.M710349200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  The heat shock cognate protein hsc73 assembles with A(1) adenosine receptors to form functional modules in the cell membrane.

Authors:  S Sarrió; V Casadó; M Escriche; F Ciruela; J Mallol; E I Canela; C Lluis; R Franco
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  Spectral imaging and linear un-mixing enables improved FRET efficiency with a novel GFP2-YFP FRET pair.

Authors:  Timo Zimmermann; Jens Rietdorf; Andreas Girod; Virginie Georget; Rainer Pepperkok
Journal:  FEBS Lett       Date:  2002-11-06       Impact factor: 4.124

3.  Regulation of heptaspanning-membrane-receptor function by dimerization and clustering.

Authors:  Rafael Franco; Meritxell Canals; Daniel Marcellino; Sergi Ferré; Luigi Agnati; Josefa Mallol; Vicent Casadó; Francisco Ciruela; Kjell Fuxe; Carmen Lluis; Enric I Canela
Journal:  Trends Biochem Sci       Date:  2003-05       Impact factor: 13.807

4.  Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons.

Authors:  O Aizman; H Brismar; P Uhlén; E Zettergren; A I Levey; H Forssberg; P Greengard; A Aperia
Journal:  Nat Neurosci       Date:  2000-03       Impact factor: 24.884

5.  Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers.

Authors:  Francisco Ciruela; Vicent Casadó; Ricardo J Rodrigues; Rafael Luján; Javier Burgueño; Meritxell Canals; Janusz Borycz; Nelson Rebola; Steven R Goldberg; Josefa Mallol; Antonio Cortés; Enric I Canela; Juan F López-Giménez; Graeme Milligan; Carme Lluis; Rodrigo A Cunha; Sergi Ferré; Rafael Franco
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

Review 6.  D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.

Authors:  D James Surmeier; Jun Ding; Michelle Day; Zhongfeng Wang; Weixing Shen
Journal:  Trends Neurosci       Date:  2007-04-03       Impact factor: 13.837

7.  S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626.

Authors:  M J Millan; A Dekeyne; J M Rivet; T Dubuffet; G Lavielle; M Brocco
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

8.  Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization.

Authors:  Chiara Fiorentini; Chiara Busi; Emanuela Gorruso; Cecilia Gotti; Pierfranco Spano; Cristina Missale
Journal:  Mol Pharmacol       Date:  2008-04-18       Impact factor: 4.436

9.  7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment.

Authors:  Laurel M Pritchard; Aaron D Logue; Scott Hayes; Jeffrey A Welge; Ming Xu; Jianhua Zhang; S Paul Berger; Neil M Richtand
Journal:  Neuropsychopharmacology       Date:  2003-01       Impact factor: 7.853

10.  Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.

Authors:  S Ridray; N Griffon; V Mignon; E Souil; S Carboni; J Diaz; J C Schwartz; P Sokoloff
Journal:  Eur J Neurosci       Date:  1998-05       Impact factor: 3.386

View more
  86 in total

Review 1.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 2.  Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Authors:  K Fuxe; D Marcellino; D O Borroto-Escuela; M Guescini; V Fernández-Dueñas; S Tanganelli; A Rivera; F Ciruela; L F Agnati
Journal:  CNS Neurosci Ther       Date:  2010-03-16       Impact factor: 5.243

Review 3.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 4.  Dopamine Receptors and Neurodegeneration.

Authors:  Claudia Rangel-Barajas; Israel Coronel; Benjamín Florán
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 5.  Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

Authors:  Pengfei Yang; Joel S Perlmutter; Tammie L S Benzinger; John C Morris; Jinbin Xu
Journal:  Ageing Res Rev       Date:  2019-11-22       Impact factor: 10.895

6.  [3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamen.

Authors:  Jinbin Xu; Babak Hassanzadeh; Wenhua Chu; Zhude Tu; Lynne A Jones; Robert R Luedtke; Joel S Perlmutter; Mark A Mintun; Robert H Mach
Journal:  Synapse       Date:  2010-06       Impact factor: 2.562

Review 7.  G-protein-coupled receptor heteromers: function and ligand pharmacology.

Authors:  R Franco; V Casadó; A Cortés; J Mallol; F Ciruela; S Ferré; C Lluis; E I Canela
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 8.  G-protein-coupled receptor heteromers or how neurons can display differently flavoured patterns in response to the same neurotransmitter.

Authors:  Rafael Franco
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

9.  [(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization.

Authors:  Jinbin Xu; Wenhua Chu; Zhude Tu; Lynne A Jones; Robert R Luedtke; Joel S Perlmutter; Mark A Mintun; Robert H Mach
Journal:  Synapse       Date:  2009-09       Impact factor: 2.562

10.  Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease.

Authors:  Vincenza Bagetta; Carmelo Sgobio; Valentina Pendolino; Giulia Del Papa; Alessandro Tozzi; Veronica Ghiglieri; Carmela Giampà; Elisa Zianni; Fabrizio Gardoni; Paolo Calabresi; Barbara Picconi
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.